Similar articles

• Inhibition of exercise-induced bronchoconstriction by MK-571, a potent leukotriene D4-receptor antagonist.

  Manning PJ, Watson RM, Margolskee DJ, Williams VC, Schwartz JI, O'Byrne PM. Manning PJ, et al. N Engl J Med. 1990 Dec 20;323(25):1736-9. doi: 10.1056/NEJM199012203232504. N Engl J Med. 1990. PMID: 2174121 Clinical Trial.
• Clinical experience with MK-571. A potent and specific LTD4 receptor antagonist.

  Margolskee DJ. Margolskee DJ. Ann N Y Acad Sci. 1991;629:148-56. doi: 10.1111/j.1749-6632.1991.tb37972.x. Ann N Y Acad Sci. 1991. PMID: 1659276 Review. No abstract available.
• Regulation of the production and action of leukotrienes by MK-571 and MK-886.

  Ford-Hutchinson AW. Ford-Hutchinson AW. Adv Prostaglandin Thromboxane Leukot Res. 1991;21A:9-16. Adv Prostaglandin Thromboxane Leukot Res. 1991. PMID: 1847788 Clinical Trial. No abstract available.
• MK-571, a potent antagonist of leukotriene D4-induced bronchoconstriction in the human.

  Kips JC, Joos GF, De Lepeleire I, Margolskee DJ, Buntinx A, Pauwels RA, Van der Straeten ME. Kips JC, et al. Am Rev Respir Dis. 1991 Sep;144(3 Pt 1):617-21. doi: 10.1164/ajrccm/144.3_Pt_1.617. Am Rev Respir Dis. 1991. PMID: 1892302 Clinical Trial.
• WY-50,295 tromethamine: a novel inhibitor of leukotriene-mediated reactions.

  Weichman BM, Berkenkopf JW, Grimes D, Heaslip RJ, Sturm RJ, Chang JY. Weichman BM, et al. Adv Prostaglandin Thromboxane Leukot Res. 1991;21A:477-80. Adv Prostaglandin Thromboxane Leukot Res. 1991. PMID: 1847784 Review. No abstract available.